Your browser doesn't support javascript.
loading
Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
Borsoi, Carlotta; Leonard, Fransisca; Lee, Yeonju; Zaid, Mohamed; Elganainy, Dalia; Alexander, Jenolyn Francisca; Kai, Megumi; Liu, Yan Ting; Kang, Yaan; Liu, Xuewu; Koay, Eugene J; Ferrari, Mauro; Godin, Biana; Yokoi, Kenji.
Afiliación
  • Borsoi C; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Leonard F; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Lee Y; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Zaid M; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Elganainy D; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Alexander JF; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Kai M; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Liu YT; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Kang Y; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Liu X; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Koay EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Ferrari M; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA; Department of Medicine, Weill Cornell Medicine, 1300 York Ave., New York, NY 10065, USA. Electronic address: mferrari@houstonmethodist.org.
  • Godin B; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA. Electronic address: bianagodinv@gmail.com.
  • Yokoi K; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA. Electronic address: kyokoi@houstonmethodist.org.
Cancer Lett ; 403: 296-304, 2017 09 10.
Article en En | MEDLINE | ID: mdl-28687352

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Neoplasias Pancreáticas / Portadores de Fármacos / Resistencia a Antineoplásicos / Carcinoma Ductal Pancreático / Desoxicitidina / Nanopartículas / Paclitaxel Unido a Albúmina / Antimetabolitos Antineoplásicos / Antineoplásicos Fitogénicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Cancer Lett Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Neoplasias Pancreáticas / Portadores de Fármacos / Resistencia a Antineoplásicos / Carcinoma Ductal Pancreático / Desoxicitidina / Nanopartículas / Paclitaxel Unido a Albúmina / Antimetabolitos Antineoplásicos / Antineoplásicos Fitogénicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Cancer Lett Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
...